Typically the commissioning and production editors (as opposed to the academic editors) are paid, as are the copyediting staff, the design staff, the sales and marketing teams (brands don't build themselves), etc.
The average academic journal has 25%-30% profit margin (higher than the rest of the publishing industry), but it can take upto 5-7 years for a new STM journal to build enough of a reputation to break even. The profits from the successful journals have to cover the failure of the others (not unlike the startup industry from an investor perspective).
If you look at an open access journal like PLOS Biology the fundamental economics aren't that different. PLOS Biology charges authors $2900/paper, at about 20 papers an issue that means an issue generates just under $60,000 in revenue (excluding revenue from print sales). Overall PLOS runs at a 20% profit rate but it's not significantly different from other mid-tier closed-access journal publishers.
But what do journals do? I know what they did: they were clearinghouses of current scientific knowledge. Now, in the days of the ArXiv, what do they do?
The only answer I can come up with is: help academics gain tenure and promotion. Except for a few flagships (Science, Nature, Cell, etc) most journals are not current, and are not read. Issues are not received with bated breath by people rushing to find out what the cutting edge is. Instead, everyone who cares has gotten the preprints, and everyone else doesn't care.
Arguing about the profitability of journals feels like arguing about the business models of buggy whip manufacturers.
The average academic journal has 25%-30% profit margin (higher than the rest of the publishing industry), but it can take upto 5-7 years for a new STM journal to build enough of a reputation to break even. The profits from the successful journals have to cover the failure of the others (not unlike the startup industry from an investor perspective).
If you look at an open access journal like PLOS Biology the fundamental economics aren't that different. PLOS Biology charges authors $2900/paper, at about 20 papers an issue that means an issue generates just under $60,000 in revenue (excluding revenue from print sales). Overall PLOS runs at a 20% profit rate but it's not significantly different from other mid-tier closed-access journal publishers.